Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

Deals > All

Total search results: 5551 | Ordered by Date (descending)
1 2 3 ... 54 55 56  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
JnJ–Medivir: antiviral, –201806 license for simeprevir to Janssen Pharmaceuticals Inc TERMINATED 6/18 2018-06-30
Curetis–Goetzpartners: investor conference, 201806 supply service Curetis presents at Goetzpartners Healhlcare Day 2018 in London 2018-06-22
Evotec–Deutsche Bank: investor conference, 201806 supply service Evotec presents at dbAccess Berlin Conference 2018-06-07
Evotec–Leucadia: investor conference, 201806 supply service Evotec AG presents at Jefferies 2018 Global Healthcare Conference NYC 2018-06-05
Evotec–Berenberg: investor conference, 201805 supply service Evotec presents at Berenberg European Conference USA in Tarrytown 2018-05-22
Evotec–Bank of America: investor conference, 201805 supply service Evotec presents at BoAML Global Healthcare Conference Las Vegas 2018-05-16
Bluebird Bio–Medigene: TCR technology, 201805– collab strategic alliance expansion incl $8m one-time payment 2018-05-14
Curetis–Informa: investor conference, 201805 supply service Curetis presents at BioEquity Europe 2018 in Ghent 2018-05-14
Pierre Fabre–BioSerenity: medical device, 201805– collab €na develop + marketing connected device for managing urinary incontinence 2018-05-14
Polyneuron–SEVERAL: investment, 201805 seed financing round CHF3.1m led by EVA Basel + incl Zürcher Kantonalbank + private investors 2018-05-14
Valerius Biopharma–Catalent: contract manufacturing, 201805– collab cell line developm + manufacturing of speciality biosimilars using GPEx technology 2018-05-14
Memo Therapeutics–Redalpine: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor Redalpine Venture Partners 2018-05-09
Memo Therapeutics–Schroders: investment, 201805 financing round Series A2 totalling CHF5m incl new investor Schroder Adveq 2018-05-09
Memo Therapeutics–SEVERAL: investment, 201805 financing round Series A2 CHF5m incl Schroder Adveq + investiere.ch + Redalpine Ventures et al. 2018-05-09
Memo Therapeutics–Verve Capital Partners: investment, 201805 financing round Series A2 totalling CHF5m incl new investor investiere.ch 2018-05-09
Memo Therapeutics–Zürcher Kantonalbank: investment, 201805 financing round Series A2 totalling CHF5m incl existing investor ZKB 2018-05-09
Rightek (TW)–Microsaic: mass spectrometer, 201805– distribution of Microsaic’s 4500 MiD MS detector in Taiwan 2018-05-09
Evotec–Deutsche Bank: investor conference, 201805 supply service Evotec presents at Deutsche Bank 43rd Annual Health Care Conference in Boston 2018-05-08
Waters–Deutsche Bank: investor conference, 201805 supply service Waters presents at Deutsche Bank 43rd Annual Health Care Conference in Boston 2018-05-08
Luye Pharma–AstraZeneca: quetiapine fumarate, 201805– acquisition of rights to Seroquel + Seroquel XR for $538m in GB + CN + et al. by Luye Pharma 2018-05-07
InflaRx–LifeSci: public relations, 201805 service existent IR by LifeSci Advisors + Media US by LifeSci Public Relations 2018-05-03
SmartDyeLivery–SEVERAL: investment, 201805 financing round from new investor STIFT + existing investors bm|t + Sparkasse Jena-Saale-Holzland 2018-05-03
UCB–Science 37: clinical research, 201805– collab to include more patients at home in clinical trials using NORA platform 2018-05-03
Unisensor (BE)–Scienion: print/spotting technology, 201805 collab use of sciFlexarrayer techn for Extenso milk analysis platform 2018-05-03
Evotec–ERS Genomics: CRISPR technology, 201804– license to expand Evotec’s CRISPR-based service offering from ERS Genomics Ltd 2018-05-02
Genohm–Agilent: investment, 201805 acquisition €na of Genohm by Agilent ANNOUNCED 2018-05-02
InflaRx–SEVERAL: investment, 201805 primary public offering $51m+$7.65m w 1.5m+225k common shares at $34/share 2018-05-02
Invizius–Mercia Technologies: investment, 201805 investment £500k by Mercia Fund Managers 2018-05-02
Harvard Univ–Cellectis: gene editing technology, 201805– collab Wyss Institute to use TALEN to recode a human genome 2018-05-01
Uniqure–SEVERAL: investment, 201805 public offering $128.25m+$19.24m with 4.5m+675k new ordinary shares at $28.5/share 2018-05-01
Crescendo Biologics–SEVERAL: investment, 201805 financing round Series B €57m led by Andera Partners 2018-04-30
LabCorp–Eurofins: investment, 201804– acquisition $670m cash/debt free of Covance Food Solutions from LabCorp by Eurofins 2018-04-30
NovellusDx–SEVERAL: investment, 201804 financing round $6m incl investors Helsinn + BCIF + Windham Venture Partners 2018-04-30
Roche–4D Molecular Therapeutics: gene delivery technology, 201804– collab expansion to develop + commercialise ophthalmic gene therapy products 2018-04-30
Roivant–SEVERAL: investment, 201804 financing round $40.5m of Datavant led by Roivant Sciences + Travis May 2018-04-30
Synthorx–SEVERAL: investment, 201804 financing round Series C $63m led by OrbiMed 2018-04-30
Universal Patient Key–Roivant: investment, 201804 acquisition of UPK by Datavant 2018-04-30
A-Mansia–BPCE: investment, 201804 financing round Series A first closing totalling €13m incl lead investor Seventure Partners 2018-04-27
A-Mansia–Instinctif Partners: public relations, 201804 service existent by Instinctif 2018-04-27
A-Mansia–SEVERAL: investment, 201804 financing round Series A first closing €13m led by Seventure Partners 2018-04-27
A-Mansia–Wallonia (govt): grant, 201804 non-dilutive grant €3m from Wallonia regional govt 2018-04-27
Curetis–Global Corporate Finance: investment, 201804–202103 equity facility $10m solely at Curetis request up to 36 months at pre-agreed floor pricing 2018-04-27
Curetis–SEVERAL: investment, 201804 capital increase €4.1m offering of 854k new ordinary shares at €4.8/share to qualified EU + US investors 2018-04-27
Jellagen–SEVERAL: investment, 201804 financing round £3.8m led by Newable Private Investing + Development Bank Wales + angel investors 2018-04-27
Polyphor–Consilium: public relations, 201804 service existent international media relations by CSC 2018-04-27
Boehringer–Topas Therapeutics: immuno modulatory compounds, 201804– collab €na multi-y research + option agreem 2018-04-24
EryDel–Genextra: investment, 201804 financing round totalling €26.5m incl existing + co-investor Genextra SpA 2018-04-24
EryDel–Innogest SGR: investment, 201804 financing round totalling €26.5m incl existing + co-investor Innogest SGR 2018-04-24
EryDel–SEVERAL: investment, 201804 financing round €26.5m led by Sofinnova Partners + incl Genextra + Innogest SGR 2018-04-24
EryDel–Sofinnova: investment, 201804 financing round totalling €26.5m inc lead investor Sofinnova Partners 2018-04-24
Onxeo–LifeSci: public relations, 201804 service existent IR US by LifeSci Advisors 2018-04-24
Onxeo–NewCap: public relations, 201804 service existent IR + strategic communication by NewCap 2018-04-24
UCB–Acova: midazolam, 201804 acquisition rights to USL261 midazolam nasal spray $150m upfront cash + $220m milestones from Proximagen LLC by UCB 2018-04-20
BenevolentAI–SEVERAL: investment, 201804 financing round $115m from new + exsiting investors incl Woodford 2018-04-19
Merck (DE)–P&G: investment, 201804 acquisition €3.4b in cash of Merck’s consumer healthcare by P&G 2018-04-19
AiCuris–Max Planck: anti-infectives, 2018004– collab discovery of antibiotics + virostatic compounds extending existent collab with MPI-MP 2018-04-18
Curetis–Van Lanschot: investor conference, 201804 supply service Curetis presents at Kempen Life Sciences Conference 2018 in Amsterdam 2018-04-18
Tizona Therapeutics–Minapharm: biopharma production, 201804– supply service cell line + process developm + production of therap antibody by ProBioGen 2018-04-18
Anasys Instruments–Bruker Corp: investment, 201804 acquisition of Anasys by Bruker 2018-04-17
DKSH–Bruker Corp: analytical instruments, 201804– distribution multi-product line of Bruker AXS in KR + AU + NZ + SG + ID by DKSH Technology 2018-04-17
Inflection Biosciences–Trinity College Dublin: cancer immunotherapy, 201804– collab research with TBSI for PIM/PI3K inhibitors 2018-04-16
LimFlow–SEVERAL: investment, 201804 financing round Series C €27m led by Sofinnova Crossover I Fund 2018-04-16
Shire–Servier: investment, 201804– acquisition of Shire’s oncology business for $2.4b in cash by Servier ANNOUNCED 2018-04-16
Enterprise Therapeutics–Epidarex Capital: investment, 201804 financing round Series B totalling £29m ($41m) incl existing co-investor Epidarex Capital 2018-04-12
Enterprise Therapeutics–Forbion: investment, 201804 financing round Series B totalling £29m ($41m) incl new + co-investor Forbion 2018-04-12
Enterprise Therapeutics–IP Group: investment, 201804 financing round Series B totalling £29m ($41m) incl existing co-investor IP Group 2018-04-12
Enterprise Therapeutics–Novartis: investment, 201804 financing round Series B totalling £29m ($41m) incl co-lead investor Novartis Venture Fund 2018-04-12
Enterprise Therapeutics–SEVERAL: investment, 201804 financing round Series B £29m ($41m) co-led by Versant Ventures + NVF 2018-04-12
Enterprise Therapeutics–Versant Ventures: investment, 201804 financing round Series B totalling £29m ($41m) incl co-lead investor Versant Ventures 2018-04-12
Enterprise Therapeutics–Zyme Communications: public relations, 201804 service existent by Zyme 2018-04-12
Knauer–Microsaic: mass spectrometry, 201804– collab integration of Microsaic’s compact MS techn in Knauer’s LC platform 2018-04-12
Orchard Therapeutics–GSK: gene therapy, 201804 transfer of GSK’s gene therapy portfolio to Orchard with 19.9% shareholding for GSK 2018-04-12
Orchard Therapeutics–GSK: investment, 201804 shareholding of 19.9% for GSK in return for transfer of gene therapy portfolio to Orchard 2018-04-12
Petra Pharma–Evotec: drug development services, 201804– supply service €na support developm of Petra-01 through to IND 2018-04-11
AveXis–Novartis: investment, 201804– acquisition $8.7b in cash of AveXis Inc by Novartis for $128/share ANNOUNCED 2018-04-09
Grünenthal–Univ Leuven: pain drugs, 201804– collab r+d non-opioid pain drugs with CD3 + LICR 2018-04-09
Polyphor–SEVERAL: investment, 201804– IPO up to CHF150m at SIX Swiss Exchange 2018-04-09
Allecra Therapeutics–HC Wainwright: investor conference, 201804 supply service Allecra presents at HC Wainwright Global Life Sciences Conference 2018-04-08
Curetis–HC Wainwright: investor conference, 201804 supply service Curetis presents at HC Wainwright Global Life Sciences Conference in Monte Carlo 2018-04-08
Element Genomics–UCB: investment, 201804 acquisition by UCB for up to $30m in upfront + short-term milestones 2018-04-05
Astute Medical–Mérieux: investment, 201804 acquisition $90m in cash by bioMérieux 2018-04-04
Boehringer–OSE Immunotherapeutics: antibody cancer drug, 201804– collab + license ww OSE-172 €30m upfront+short-term + €1.1b milestones + royalties 2018-04-04
Igem Therapeutics–Iontas: antibody cancer drug, 201804– collab identification IgE antibodies against two cancer targets 2018-04-04
Iontas–Zyme Communications: public relations, 201804 service existent by Zyme 2018-04-04
LCF Rothschild–Andera Partners: investment, 201804 management buy-out of EdRIP by employees + renaming to Andera Partners 2018-04-04
Sofinnova–SEVERAL: investment, 201804 1st closing €275m of Sofinnova Crossover I fund 2018-04-04
Allogene Therapeutics–Cellectis: T-cell immunotherapy, 201804– collab continuation of Pfizer-Cellectis collaboration signed 201406 by Allogene 2018-04-03
Axonics–Gilde Investment: investment, 201804 financing round totalling $20.1m led by Longitude Capital + incl existing investor Gilde Healthcare 2018-04-03
Axonics–SEVERAL: investment, 201804 financing round $20.1m led by Longitude Capital + incl existing investor Gilde Healthcare 2018-04-03
Brainomix–Boehringer: investment, 201804 financing round totalling £7m incl new + co-investor BIVF 2018-04-03
Brainomix–SEVERAL: investment, 201804 financing round £7m led by Parkwalk Advisors + incl BIVF + Chimera Partners + Oxford Univ 2018-04-03
Cellectis–SEVERAL: investment, 201804 public offering $175m ($163.7m net) with 5.646m ADSs at $31/ADS 2018-04-03
Young In Group–Eurofins: investment, 201804 acquisition of Lab Frontier Co Ltd from YIG by Eurofins 2018-04-03
AstraZeneca–Compugen: antibody cancer drug, 201804– license $10m upfront + $200m milestones + royalties developm bi-/multi-specific ABs to MedImmune 2018-04-02
Eagle Genomics–SEVERAL: investment, 201804–201806 financing round ongoing with $1m raised until 1st May 2018-04-01
Inari Medical–Gilde Investment: investment, 201803 financing round Series C totalling $27m incl new + lead investor Gilde Healthcare 2018-03-29
Inari Medical–SEVERAL: investment, 201803 financing round Series C $27m new + lead investor Gilde Healthcare + all existing investors 2018-03-29
Unimicro Technologies–Microsaic: mass spectrometer, 201803– collab integration of 4500 MiD MS detector w Unimicro CEO products for sale in China 2018-03-28
Arsanis–Needham: investor conference, 201803 supply service Arsanis presents at Annual Needham Healthcare Conference in NY 2018-03-27
Medigene–Needham: investor conference, 201803 supply service Medigene presents at Annual Needham Healthcare Conference in NY 2018-03-27
1 2 3 ... 54 55 56  next pagenext page



Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px